ADD ANYTHING HERE OR JUST REMOVE IT…
Wrong menu selected
Acarix Acarix
  • Product

    Background

    • What is Coronary Artery Disease (CAD)?
    • Diagnosing CAD

    About the product

    • The CADScor® System
    • How does it work
  • Resources

    Testimonials

    • HCP stories
    • Patient stories

    References

    • Clinical Studies
    • Questionnaire
    • Downloads (US)
    • Downloads (EU)
    • Education

    Support

    • Training
    • FAQ
    • Reimbursement

    Physician Locator

    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Rights Issue/Warrant Program
    • Previous Rights Issue
    • Investor Presentations
  • Company

    Who we are

    • About Acarix
    • leadership
    • Join the team

    Get in touch

    • Contact us
    • Investigator Initiated Study
  • News
    • Press
    • Events
    • Social Media
Account
Search
Book a Demo
Acarix Acarix
Book a demo
Menu
author-avatar acarix
Press
August 6, 2024
09 Nov 2023

Acarix AB (publ) publishes Interim Report, July – September 2023

Continued momentum in the US and strengthened financing in place We are pleased with the Q3 revenue growth in the US, where we are maki...
Continue reading
author-avatar acarix
Press
August 6, 2024
09 Nov 2023

Acarix AB (publ) publicerar delårsrapport, juli – september 2023

Fortsatt momentum i USA och stärkt finansiering på plats Vi är nöjda med intäktstillväxten i USA under Q3, där vi gör betydande investe...
Continue reading
author-avatar acarix
Press
August 6, 2024
06 Nov 2023

Last day of trading in paid subscribed units in Acarix’ unit rights issue is 9 November 2023

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, WHETHER DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, ...
Continue reading
author-avatar acarix
Press
August 6, 2024
06 Nov 2023

Sista dag för handel i BTU i Acarix företrädesemission av units är 9 november 2023

EJ FÖR OFFENTLIGGÖRANDE, DISTRIBUTION ELLER PUBLICERING, VARE SIG DIREKT ELLER INDIREKT, INOM ELLER TILL USA, AUSTRALIEN, HONGKONG, JAP...
Continue reading
author-avatar acarix
Press
August 6, 2024
20 Oct 2023

Acarix announces final outcome in the rights issue

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, WHETHER DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, ...
Continue reading
author-avatar acarix
Press
August 6, 2024
20 Oct 2023

Acarix offentliggör slutligt utfall i företrädesemissionen

EJ FÖR OFFENTLIGGÖRANDE, DISTRIBUTION ELLER PUBLICERING, VARE SIG DIREKT ELLER INDIREKT, INOM ELLER TILL USA, AUSTRALIEN, HONGKONG, JAP...
Continue reading
author-avatar acarix
Press
August 6, 2024
03 Oct 2023

Acarix publishes prospectus in connection with the company’s fully guaranteed rights issue

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, WHETHER DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, ...
Continue reading
author-avatar acarix
Press
August 6, 2024
03 Oct 2023

Acarix offentliggör prospekt i samband med bolagets fullt garanterade företrädesemission

EJ FÖR OFFENTLIGGÖRANDE, DISTRIBUTION ELLER PUBLICERING, VARE SIG DIREKT ELLER INDIREKT, INOM ELLER TILL USA, AUSTRALIEN, HONGKONG, JAP...
Continue reading
author-avatar acarix
Press
August 6, 2024
14 Sep 2023

Acarix byter Certified Adviser till Penser Bank AB

Acarix, ledande inom akustisk och AI-baserad hjärtdiagnostik, meddelar idag att man byter Certified Adviser. Acarix AB har ingått avtal...
Continue reading
author-avatar acarix
Press
August 6, 2024
14 Sep 2023

Acarix changes Certified Adviser to Penser Bank AB

Acarix, a leader in acoustic and AI-based cardiac diagnostics, today announces a change of Certified Adviser. Acarix AB has entered int...
Continue reading
author-avatar acarix
Press
August 6, 2024
31 Aug 2023

Acarix AB (publ) publishes Interim Report, April – June 2023

Traction in the US market reflects transition to a new expanded commercial model In 2022, we initiated the transition of Acarix to full...
Continue reading
author-avatar acarix
Press
August 6, 2024
31 Aug 2023

Acarix AB (publ) publicerar delårsrapport, april – juni 2023

Dragkraft på den amerikanska marknaden återspeglar övergången till en ny kommersiell modell Under 2022 påbörjades omställningen av Acar...
Continue reading
  • ‹
  • 1
  • 2
  • 3
  • 4
  • 5
  • ›
  • »
Acarix AB
Jungmansgatan 12
211 19 Malmö
SE
[email protected]

Product

Background

  • What is Coronary Artery Disease (CAD)?
  • Diagnosing CAD

About the product

  • The CADScor® System
  • How does it work

Resources

Testimonials

  • HCP stories
  • Patient stories

Support

  • Training
  • FAQ

References

  • Clinical Studies
  • Downloads (US)
  • Downloads (EU)

Investors

  • Corporate Governance
  • General Meetings
  • Financial Reports and Calendar
  • The Acarix Share
  • Rights Issue
  • Investor Presentations

Company

Who we are

  • About Acarix
  • Management
  • Join the team

Get in touch

  • Contact us
  • LinkedIn
  • Twitter

News

  • Press
  • Events
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy

Acarix, 2025. All rights reserved V5

  • Products
    • Background
    • What is Coronary Artery Disease
    • Diagnosing CAD
    • About the product
    • The Cadscor System
    • How Does it Work
  • Resources
    • Testimonial
    • HCP Stories
    • Patients Stories
    • References
    • Clinical Studies
    • Downloads (US)
    • Downloads (EU)
    • Support
    • Training
    • Faq
    • Reimbursement
    • Physician Locator
    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Right Issue
    • Previous Rights Issue
    • Investor Presentations
  • Company
    • Who we are
    • About Acarix
    • Leadership
    • Join The Team
    • Get in touch
    • Contact Us
    • Investigator Initiated Study
  • News
    • News
    • Press
    • Events
    • Socialmedia
Start typing to see products you are looking for.